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Abstract. Cherenkov radiation is induced when charged
particles travel through dielectric media (such as biological
tissue) faster than the speed of light through that medium.
Detection of this radiation or excited luminescence during
megavoltage external beam radiotherapy (EBRT) can allow
emergence of a new approach to superficial dose estima-
tion, functional imaging, and quality assurance for radiation
therapy dosimetry. In this letter, the first in vivo Cherenkov
images of a real-time Cherenkoscopy during EBRT are pre-
sented. The imaging system consisted of a time-gated inten-
sified charge coupled device (ICCD) coupled with a
commercial lens. The ICCD was synchronized to the linear
accelerator to detect Cherenkov photons only during the
3.25-μs radiation bursts. Images of a tissue phantom under
irradiation show that the intensity of Cherenkov emission is
directly proportional to radiation dose, and images can be
acquired at 4.7 frames∕s with SNR > 30. Cherenkoscopy
was obtained from the superficial regions of a canine oral
tumor during planned, Institutional Animal Care and Use
Committee approved, conventional (therapeutically appro-
priate) EBRT irradiation. Coregistration between photogra-
phy and Cherenkoscopy validated that Cherenkov photons
were detected from the planned treatment region. Real-time
images correctly monitored the beam field changes corre-
sponding to the planned dynamic wedge movement, with
accurate extent of overall beam field, and expected cold
and hot regions. © The Authors. Published by SPIE under a Creative
Commons Attribution 3.0 Unported License. Distribution or reproduction of
this work in whole or in part requires full attribution of the original publication,
including its DOI. [DOI: 10.1117/1.JBO.18.11.110504]
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Cherenkov radiation emission occurs in all dielectric media
(such as water and biological tissue) when charged particles
move with phase velocity greater than the speed of light in that
medium.1 This Cherenkov effect produces a broad spectrum of
light emission from UV down to near-infrared, with a spectrum
described by the Frank-Tamm formula, varying as the inverse
square of wavelength.2 Recent work has shown, in phantoms,
small animals,3 and clinical patients,4 that Cherenkov emission
is generated by βþ and β− emitters in diagnostic (18-FDG) and
nuclear medicine (131-I) applications. However, to date,
Cherenkov radiation emission has never been imaged in vivo
during external beam radiation therapy (EBRT), where there
is considerable signal throughout the treated regions of tissue.
In this letter, we present the first linearity test between surface
dose and Cherenkov emission in a phantom, followed by the
first video sequence of Cherenkov emission in vivo. This imag-
ing is here named Cherenkoscopy, for the parallel between fluo-
roscopy but with surface imaging of Cherenkov signal. The
imaging was performed while a dog was undergoing planned
EBRT for treatment of a spontaneous oral tumor.
The occurrence of Cherenkov radiation in water during meg-
avoltage EBRT with both electron and photon beams has been
demonstrated in several recent papers.5,6 Based on the detection
of Cherenkov radiation or excited luminescence during EBRT,
techniques such as radiation beam profiling,6–8 oximetry,9,10 and
superficial radiation dosimetry have been investigated in phan-
toms.11,12 While the utility of this emission is still under inves-
tigation, the applications are likely dependent on the ease of
imaging and the frame rate of acquisition. In this study, the
goal was to assess the feasible frame rate for imaging emission
from tissue and confirm that there would be sufficient signal to
noise for near real-time imaging.
The experimental configuration is shown in Fig. 1(a). The
external beam irradiator was a Varian Clinic 2100CD linear
accelerator (LINAC, Varian Medical Systems, Palo Alto, CA).
A time-gated intensified charge coupled device (ICCD) camera
was set up on a tripod to image the entrance region of the treat-
ment beam on tissue phantoms or tissue. The LINAC delivers
radiation in pulsed mode, as described in Fig. 1(b), and the
ICCD camera was synchronized to the 3-μs radiation bursts,
detecting Cherenkov emission effectively and rejecting most
of the ambient light.13 This imaging system was first tested by
imaging Cherenkov emission from a slab (30 × 30 × 4 cm3)
phantom made of opaque water equivalent plastic while irradi-
ating it with a 6 MV square (10 × 10 cm2) photon beam at a
dose rate of 600 monitor units (MU, 1 MU ¼ 1 cGy for
10 × 10 cm2 field at dmax) per minute. Cherenkov images for
different delivered doses at dmax (0.5 to 25 cGy) were acquired.
After background subtraction, the Cherenkov images of the
flat phantom for dose at dmax from 0.5 to 25 cGy (corresponding
to fps from 7 to 0.68) are shown in Fig. 2(a). It has been shown
by Archambault et al.,14 for CCD cameras, that median filtering
is an effective method for sparkle noise removing. To remove
the sparkle noisy pixels caused by high-energy photon hitting
the ICCD directly, each image was generated by median filtering
over a stack of three images from repetitive measurements
and then smoothed by a median filter with kernel size of
10 pixels × 10 pixels. The signal-to-noise ratio (SNR) of
images acquired with different frame rates from 0.68 to 7
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were calculated (mean value over the standard deviation) based
on a chosen region (100 pixels × 100 pixels around the center)
as indicated by a dotted red box in Fig. 2(a). SNR values were
plotted with the corresponding frame rates in Fig. 2(b). To
ensure relatively good image quality as well as real-time data
acquisition, an accumulation of 50 radiation bursts
(fps ¼ 4.7) for each image was chosen as the imaging procedure
for the following in vivo imaging. The average pixel value of
each image was calculated and plotted with the corresponding
delivered dose in Fig. 2(c). Least square linear fitting was
applied and the results of the fitting are listed in Fig. 2(c).
The good linearity (R2 ¼ 1) between Cherenkov intensity
and delivered dose suggests that Cherenkoscopy could be a
novel technique for superficial dose estimation. Our previous
work focusing on a phantom study validated that, in tissue
equivalent phantom, Cherenkov emission could sample super-
ficial dose up to 6 mm and could be taken as surrogate of radi-
ation dose in the sampling region with average discrepancy of
1%.11,12 Within the scope of this short note, we focus on vali-
dating the fast imaging capabilities of Cherenkoscopy in vivo
and correlate this signal to superficial dose qualitatively within
the process of EBRT.
As shown in Fig. 3(a), a treatment plan was designed in
Eclipse independently to treat a dog with a spontaneous oral
tumor without considering the process of Cherenkoscopy.
The LINAC was set to irradiate the treatment region with
6 MV photon beam, at a dose rate of 600 MU∕min. A total
dose of 59 MU (reference dose of 60.5 cGy) was delivered.
A dynamic wedge [indicated in Fig. 3(a)] was designed to con-
trol the beam dynamically during the treatment, delivering a
homogenous dose distribution even in the presence of complex
tissue geometry. Detailed information about the treatment field
and the dynamic wedge are listed in Table 1. In order to deliver
radiation dose to the tumor, high-energy radiation has to incident
on the surface externally and results in certain amount of radi-
ation dose to be deposited near the surface. The deposited
dose near the surface of the treatment region was predicted
by Eclipse and shown in Fig. 3(a). Since phantom studies vali-
dated that image quality (SNR > 30) and fast imaging capabil-
ity (fps ¼ 4.7) are balanced by an accumulation of 50 radiation
bursts, Cherenkoscopy was acquired using this acquisition pro-
cedure. The tungsten light in the radiotherapy room was turned
on to provide a reasonable level of ambient light while imaging.
The background image was acquired with the same procedure
before the treatment (radiation off), and background subtraction
was applied simultaneously during the process of data
acquisition. Figure 3(b) shows the photographic view of the
Fig. 1 (a) Relative positions of the linear accelerator (LINAC) gantry,
treatment region, and the time-domain gated system. The intensified
charge coupled device (ICCD) was synchronized to radiation bursts
from the LINAC and Cherenkoscopy were taken from the beam incident
on the treatment regions. (b) Timeline about the temporal gating.
Fig. 2 (a) Cherenkoscopy from a 6 MV square (10 × 10 cm2) photon
beam incident normally on a tissue phantom (30 × 30 × 4 cm3) of
opaque water equivalent phantom at SSD ¼ 100 cm with delivered
dose at dmax varying from 0.5 to 25 cGy. (b) Signal-to-noise ratio of
Cherenkov images with fps from 0.68 to 7. (c) Linearity between inten-
sity of Cherenkov emission from the surface and delivered dose is estab-
lished under these controlled conditions.
Fig. 3 (a) The treatment plan shows incident of the beam and dynamic wedge. Surface dose was calculated by the treatment planning system (Eclipse)
and mapped on the surface of the treatment region. (b) Field view of the treatment region from the gated ICCD system. (c) Cherenkoscopy of the
treatment region while irradiation progresses. (d) Cherenkoscopy overlaid on the white-light images of the treatment field and sequence of
Cherenkoscopy showing the beam field changing while a wedge is moved into the beam to shape the integrated dose on the field. (Video 1,
MOV, 19.5 MB) [URL: http://dx.doi.org/10.1117/1.JBO.18.11.110504.1].
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entrance region from the imaging system. The colorized in vivo
Cherenkoscopy [Fig. 3(c)] corresponding to the treatment
plan described in Fig. 3(a) and Table 1 was generated by aver-
aging all the frames of images taken during the treatment and
smoothed by a median filter with kernel size of 10 pixels×
10 pixels. In the first image of Fig. 3(d), Cherenkoscopy
was coregistered to the photographic view by adding the
Cherenkoscopy to the blue channel. It can be validated that
the detected Cherenkov emission is from the treatment region.
To the extent of overall beam field shape, hot and cold regions,
the Cherenkoscopy [Fig. 3(c)] shows similar distribution com-
pared with the predicted surface dose [Fig. 3(a)]. The hot
regions in Cherenkoscopy around the teeth disagree with the
predicted dose due to the relatively low absorption of
Cherenkov photons by the teeth. Figure 3(d) shows frames of
coregistered Cherenkoscopy monitored throughout the entire
treatment. To remove the noise caused by high-energy photons
hitting the ICCD directly, images were processed by median fil-
tering over a stack of images including the two adjacent frames
and then smoothed by a median filter with kernel size of
10 pixels × 10 pixels. Beam changes corresponding to the
planned dynamic wedge were monitored by Cherenkoscopy
in real time (fps ¼ 4.7). A video (Video 1) of Cherenkoscopy
of this treatment was produced with processed frames.
Video 1 shows the monitoring of the entire treatment based
on Cherenkoscopy, including the field changes due to the
dynamic wedge movement at the end of the video.
In this study, we demonstrated that the concept of in vivo
Cherenkoscopy is feasible in real time during EBRT, with accept-
able SNR. It has been shown that Cherenkov emission is directly
proportional to the delivered radiation surface dose in a tissue
equivalent phantom [Fig. 2(c)]. The relatively low absorption
of Cherenkov photons in the teeth lead to hot regions in
Cherenkoscopy and a disagreement with the predicted surface
dose. However, in the regions where the optical properties are
relatively homogenous, Cherenkoscopy [Fig. 3(c)] shows similar
hot and cold regions as compared to the predicted surface dose
[Fig. 3(a)]. The next stage of evaluation of this technology will be
in vivo Cherenkoscopy of human patients to monitor treatments,
correlate superficial dose and resulted skin reactions to hot
regions viewed by Cherenkoscopy. Most likely, patients who
undergo EBRT will be treated by 10 to 30 of fractions. If the
superficial dose can be measured accurately in the early fractions,
treatment plan for the following fractions of treatments could
potentially be modified to avoid hot regions on the surface.
With the ability to image treatment fields on the surface of the
treatment region [Fig. 3(d) and Video 1] in real time, beam
changes due to the motion of a dynamic wedge or multileaf col-
limators could be monitored to make sure treatments are delivered
as planned.
In conclusion, in vivo Cherenkoscopy was acquired for the
first time during EBRT in an animal undergoing standard radia-
tion treatment for an oral tumor. This imaging is a novel approach
for beam field monitoring and could be extended to radiation dose
assessing in real time on the tissue surface during EBRT.
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Table 1 Parameters of the treatment plan.
Technique Machine/energy Gantry (deg) Collimator (deg) Couch (deg) Wedge
STATIC-I CD 120 - 6X 90.0 180.0 180.0 EDW20OUT
Field X (cm) X1 (cm) X2 (cm) Field Y (cm) Y1 (cm) Y2 (cm)
5.4 þ3.5 þ1.9 5.9 þ1.6 þ4.2
X (cm) Y (cm) Z (cm) SSD (cm) Monitor units Ref. dose (cGy)
−2.48 −1.52 −1.26 95.0 59 60.5
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